Importer of Controlled Substances Application: Chattem Chemicals, Inc., 61368 [2022-21940]
Download as PDF
61368
Federal Register / Vol. 87, No. 195 / Tuesday, October 11, 2022 / Notices
DEPARTMENT OF JUSTICE
Drug
code
Controlled substance
Schedule
Drug Enforcement Administration
[Docket No. DEA–1083]
Importer of Controlled Substances
Application: Chattem Chemicals, Inc.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Chattem Chemicals, Inc. has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before November 10, 2022. Such
persons may also file a written request
for a hearing on the application on or
before November 10, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on August 4, 2022,
Chattem Chemicals, Inc., 3801 Saint
Elmo Avenue, Chattanooga, Tennessee
37409–1237, applied to be registered as
an importer of the following basic
class(es) of controlled substance(s):
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:37 Oct 07, 2022
Jkt 259001
Methamphetamine ........
4-Anilino-N-phenethyl-4piperidine (ANPP).
Phenylacetone ..............
Poppy Straw Concentrate.
Tapentadol ....................
1105
8333
II
II
8501
9670
II
II
9780
II
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for sale to its customers. The company
plans to import an intermediate of
Tapentadol (9780), to bulk manufacture
Tapentadol for distribution to its
customers. No other activities for these
drug codes are authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–21940 Filed 10–7–22; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
[OMB 1121–NEW]
Agency Information Collection
Activities; Proposed Collection
Comments Requested; New Collection:
Office of Justice Programs Territories
Financial Support Center (OJP TFSC)
Needs Assessment and Evaluation
Package
Office of Justice Programs,
Department of Justice.
ACTION: 60-Day notice.
AGENCY:
estimated public burden or associated
response time, suggestions, or need a
copy of the proposed information
collection instrument with instructions
or additional information, please
contact Bethany Hemphill, Office of
Justice Programs, U.S. Department of
Justice, 810 7th Street NW, Washington,
DC 20530. Written comments and/or
suggestions can also be directed to the
Office of Management and Budget,
Officer of Information and Regulatory
Affairs, Attention Department of Justice
Desk Officer, Washington, DC 20503 or
send to OIRA_submissions@
omb.eop.gov.
This
process is conducted in accordance with
5 CFR 1320.10. Written comments and
suggestions from the public and affected
agencies concerning the proposed
collection of information are
encouraged. Your comments should
address one or more of the following
four points:
• Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
• Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
• Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
• Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses.
SUPPLEMENTARY INFORMATION:
SUMMARY:
Overview of This Information
Collection
If
you have comments, especially on the
1. Type of Information Collection:
New Information Collection.
2. The Title of the Form/Collection:
OJP TFSC Needs Assessment and
Evaluation Package.
3. The agency form number and
agency component sponsoring the
collection: NA. Office of Justice
Programs, U.S. Department of Justice.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Territory agencies/
organizations.
Abstract: The Office of Justice
Programs Territories Financial Support
The Office of Justice
Programs, U.S. Department of Justice,
will be submitting the following
information collection request to the
Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The proposed
information collection is published to
obtain comments from the public and
affected agencies.
DATES: The purpose of this notice is to
allow for an additional 60 days for
public comment until December 12,
2022.
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
E:\FR\FM\11OCN1.SGM
11OCN1
Agencies
[Federal Register Volume 87, Number 195 (Tuesday, October 11, 2022)]
[Notices]
[Page 61368]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-21940]
[[Page 61368]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1083]
Importer of Controlled Substances Application: Chattem Chemicals,
Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Chattem Chemicals, Inc. has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
November 10, 2022. Such persons may also file a written request for a
hearing on the application on or before November 10, 2022.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on August 4, 2022, Chattem Chemicals, Inc., 3801 Saint
Elmo Avenue, Chattanooga, Tennessee 37409-1237, applied to be
registered as an importer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Methamphetamine........................ 1105 II
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Phenylacetone.......................... 8501 II
Poppy Straw Concentrate................ 9670 II
Tapentadol............................. 9780 II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture bulk controlled substances for sale to its customers. The
company plans to import an intermediate of Tapentadol (9780), to bulk
manufacture Tapentadol for distribution to its customers. No other
activities for these drug codes are authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2).
Authorization will not extend to the import of Food and Drug
Administration-approved or non-approved finished dosage forms for
commercial sale.
Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-21940 Filed 10-7-22; 8:45 am]
BILLING CODE P